Sharechat Logo

New Capital Market at a glance

Friday 12th May 2000

Text too small?

  • NCM companies come to the market issuing only a single class of share.

  • The maxiµmum amount which can be raised by the IPO is $600,000.

  • Organising brokers arrange, before listing, at least 300 shareholders to hold no more than 2% each, raising a total amount of between $400,000 and $600,000.

  • Every NCM must have at least three directors. The directors are the promoters.

  • Promotors must invest their own cash of between $200,000 and $600,000.

  • Promoters will be issued shares at $0.25 and the public in the IPO at $0.50.

  • The NCM company will be listed for trading as a "cashbox" shell.

  • The promotors may already have a prospective key transaction in mind but in other cases the NCM company could be a pure cashbox looking for an investment.

  • The key transaction is subject to an independent valuation and audit report.

  • The key transaction can be made by issuing more shares to the public for cash, or by issuing shares for the key transaction business or assets.

  • Promoters can sell down their shares each year one-third at a time.

  • No more than 30% of invested funds can be spent on administration before the key transaction.

      General Finance Advertising    

    Comments from our readers

    No comments yet

    Add your comment:
    Your name:
    Your email:
    Not displayed to the public
    Comment:
    Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

    Related News:

    FBU - Fletcher Building Announces Director Appointment
    December 23rd Morning Report
    MWE - Suspension of Trading and Delisting
    EBOS welcomes finalisation of First PWA
    CVT - AMENDED: Bank covenant waiver and trading update
    Gentrack Annual Report 2024
    December 20th Morning Report
    Rua Bioscience announces launch of new products in the UK
    TEM - Appointment to the Board of Directors
    December 19th Morning Report